Maraganore replaces Tessier-Lavigne as Agios chairman

Cancer and Orphan disease company Agios Pharmaceuticals Inc. (NASDAQ:AGIO) said Marc Tessier-Lavigne resigned as its chairman "due to other commitments." John Maraganore, a director who is also CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), will succeed him.

Tessier-Lavigne is to become president of Stanford University on Sept. 1. He is stepping down as president of The Rockefeller University (see Biocentury Extra, Feb. 4). ...